Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,110 | -26,861 | -17,024 | -11,335 | -3,621 |
| Depreciation Amortization | 515 | 2,387 | 1,779 | 1,231 | 667 |
| Accounts receivable | 257 | -193 | -4 | -173 | 13 |
| Other Working Capital | -2,740 | -2,046 | -4,048 | -2,781 | -894 |
| Other Operating Activity | -166 | 716 | 1,101 | 596 | 276 |
| Operating Cash Flow | $-9,245 | $-25,997 | $-18,195 | $-12,462 | $-3,558 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -1,806 | 8,547 | -1,291 | -1,010 |
| Purchase Of Investment | N/A | N/A | 49 | 9,934 | 10,026 |
| Purchase Sale Intangibles | -16 | -150 | -141 | -133 | -36 |
| Other Investing Activity | -8 | 10,237 | -142 | -134 | -37 |
| Investing Cash Flow | $-140 | $8,431 | $8,453 | $8,509 | $8,980 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,006 | 1,926 | 1,932 | 975 |
| Debt Issued | 996 | N/A | N/A | N/A | N/A |
| Debt Repayment | -2,396 | -1,886 | -1,140 | -86 | -71 |
| Common Stock Issued | N/A | 27,964 | 17,763 | N/A | N/A |
| Other Financing Activity | -577 | -3,208 | -2,517 | -1,965 | -467 |
| Financing Cash Flow | $-1,976 | $24,876 | $16,033 | $-119 | $437 |
| Exchange Rate Effect | -34 | -75 | 131 | 132 | 17 |
| Beginning Cash Position | 33,993 | 26,997 | 25,920 | 26,001 | 26,243 |
| End Cash Position | 22,597 | 34,232 | 32,342 | 22,061 | 32,119 |
| Net Cash Flow | $-11,395 | $7,235 | $6,422 | $-3,941 | $5,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,245 | -25,997 | -18,195 | -12,462 | -3,558 |
| Capital Expenditure | -132 | -1,859 | -1,357 | -1,346 | -1,010 |
| Free Cash Flow | -9,376 | -27,856 | -19,552 | -13,808 | -4,568 |